Biological Materials

Example Definitions of "Biological Materials"
Biological Materials. Certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials may be described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances... routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). View More
View All 5 Variations
Biological Materials. Certain The tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials may be described on Exhibit A, as well as tangible materials that are routinely may be produced through use of the original materials, including, for example, including without limitation, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of... isolated DNA or RNA, and substances routinely that may be produced and/or purified from a source material included in the original materials (such as as, bacterial cell products or recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). View More
Biological Materials. Certain The tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials may be described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances... routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company. View More
Biological Materials. Certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials may be are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances... routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company. View More
View Variations
Biological Materials. The term "Biological Materials" shall mean any Technology in the form of tangible materials together with any progeny, mutants, or derivatives thereof developed in performance of the Research Program.
Biological Materials. The term "Biological Materials" 'Biological Materials' shall mean any Technology in the form of tangible materials together with any progeny, mutants, or derivatives thereof developed in performance of the Research Program.
View Variations
Biological Materials. Tangible biological materials that, to the extent that CSHL has a right to transfer such materials, are necessary for the effective exercise of the Patent Rights and are actually provided by Dr. Hannon or a member of Dr. Gregory Hannon's lab to the Company, as well as additional tangible materials that are routinely produced through use of those materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from... isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as, recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). Dr. Hannon will secure the approval of CSHL and/or, as needed, the Howard Hughes Medical Institute (HHMI) prior to the transfer of any such Biological Material to Company. View More
Biological Materials. Any plant, seed, propagule, embryo, leaf, root and/or other plant part or tissue, and/or gene construct or fragment thereof, belonging to or produced for the Company and/or its Affiliates, including any of the foregoing produced by Employee or produced by others during Employee's employment with the Company.
All Definitions